Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Motor network efficiency and disability in multiple sclerosis.
[Is it always useful to perform lumbar puncture for the diagnosis of multiple sclerosis? Comment].
EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
["Time is brain" in relapsing remitting multiple sclerosis : Current treatment concepts in immunotherapy].
Gender differences in caregiver strain, needs for support, social support, and quality of life among spousal caregivers of persons with multiple sclerosis.
Multiple sclerosis in the very young: a case report and review of the literature.
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.
[Corticotherapy and suicidal behavior: A case report].
Cyclic AMP and Polyamines Overcome Inhibition by Myelin-Associated Glycoprotein through eIF5A-Mediated Increases in p35 Expression and Activation of Cdk5.
Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditions.
Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy.
Neuroglial alterations in the zebrafish brain exposed to cadmium chloride.
Multiple sclerosis and pregnancy; What a neurologist may be asked for?
Anxiety, depression and impaired health-related quality of life are therapeutic challenges in patients with multiple sclerosis.
Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.
CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.
Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.
Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice.
Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases.
A case series of autoimmune diseases accompanied by incidentally diagnosed monoclonal gammopathy: Is there a link between the two diseases?
Medical, functional, and legal aspects of vocational rehabilitation for people with multiple sclerosis.
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis.
Psychosocial difficulties from the perspective of persons with neuropsychiatric disorders.
Schwann cells and their transcriptional network: Evolution of key regulators of peripheral myelination.
Bone marrow-derived macrophages and the CNS: An update on the use of experimental chimeric mouse models and bone marrow transplantation in neurological disorders.
Pages
« first
‹ previous
…
600
601
602
603
604
605
606
607
608
…
next ›
last »